Biggest News Aggregation in the World
📰 Nasdaq Hook News

Page 3 - Nasdaq Hook News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Nasdaq Hook. Real-time updates on events, politics, business and more.

Hookipa Pharma Inc (NASDAQ:HOOK) Given Average Rating of "Buy" by Analysts

Shares of Hookipa Pharma Inc (NASDAQ:HOOK – Get Rating) have received a consensus recommendation of “Buy” from the nine ratings firms that are currently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year price […]
Hookipa Pharma Hookipa Pharma Inc Alyeska Investment Group Goldman Sachs Group Inc Mirabella Financial Services Zacks Investment Research

Analysts Set Hookipa Pharma Inc (NASDAQ:HOOK) Price Target at $9.00

Hookipa Pharma Inc (NASDAQ:HOOK – Get Rating) has received a consensus recommendation of “Buy” from the nine ratings firms that are currently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price objective among analysts […]
Nova Scotia Hookipa Pharma Hookipa Pharma Inc Hookipa Pharma Company Profile Get Rating Goldman Sachs Group Inc Zacks Investment Research

HC Wainwright Reiterates "Buy" Rating for Hookipa Pharma (NASDAQ:HOOK)

HC Wainwright reaffirmed their buy rating on shares of Hookipa Pharma (NASDAQ:HOOK – Get Rating) in a report issued on Friday morning, TipRanks reports. The firm currently has a $8.00 price target on the stock. Other research analysts also recently issued reports about the company. UBS Group downgraded Hookipa Pharma from a buy rating to […]
Hookipa Pharma Morgan Stanley Northern Trust Corp Charles Schwab Investment Management Inc Zacks Investment Research Nuveen Asset Management

Hookipa Pharma (NASDAQ:HOOK) Announces Quarterly Earnings Results

Hookipa Pharma (NASDAQ:HOOK – Get Rating) announced its earnings results on Thursday. The company reported ($0.65) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.53) by ($0.12), MarketWatch Earnings reports. Hookipa Pharma had a negative net margin of 339.35% and a negative return on equity of 50.48%. During the same […]
Thomson Reuter Hookipa Pharma Hookipa Pharma Company Profile Get Rating Goldman Sachs Group Inc Pharma Inc Barclays Plc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science